BOSTON - Daryl Tan-Yeung Lau, MD, MSc, MPH, has been named director of translational liver research in the division of gastroenterology at Beth Israel Deaconess Medical Center (BIDMC).
Lau, a resident of Boston, is a National Institutes of Health (NIH)-funded investigator who specializes in chronic liver diseases, hepatitis B and C, HIV/hepatitis co-infection and nonalcoholic fatty liver disease. The focus of her work in the liver research program is to develop multidisciplinary approaches to better understand the pathogenesis and natural history of liver disease as a prerequisite to drug and vaccine discovery.
Together with other investigators at the BIDMC Liver Center, Lau will conduct clinical trials to evaluate new therapies for liver disease, especially viral hepatitis. Additionally, she will provide clinical care for patients.
Lau received her medical degree from McGill University in Montreal. She holds a master of science degree from Queen's University in Kingston, Ontario, Canada, where she also completed resident training in internal medicine and fellowship training in gastroenterology. She also holds a master of public health degree from Johns Hopkins University in Baltimore.
She comes to BIDMC from the University of Texas Medical Branch in Galveston, where she was director of clinical viral hepatitis in the department of medicine.
Beth Israel Deaconess Medical Center is a major patient care, teaching and research affiliate of Harvard Medical School, and ranks third in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a founding member of the Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox.